Lantern Pharma Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Lantern Pharma's estimated annual revenue is currently $1.5M per year.(i)
  • Lantern Pharma's estimated revenue per employee is $48,774

Employee Data

  • Lantern Pharma has 31 Employees.(i)
  • Lantern Pharma grew their employee count by 7% last year.

Lantern Pharma's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
VP Clinical DevelopmentReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Financial Officer and SecretaryReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
CEO, President and DirectorReveal Email/Phone
7
Chief Scientific OfficerReveal Email/Phone
8
Senior Finance ManagerReveal Email/Phone
9
Senior Research Scientist & Program ManagerReveal Email/Phone
10
Bioinformatics & Platform Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.9M65-44%$33.2MN/A
#2
$1.3M167%N/AN/A
#3
$11.9M85-11%$18.3MN/A
#4
$2.8M29-87%N/AN/A
#5
$1.3M15N/AN/AN/A
#6
$0.8M10-60%N/AN/A
#7
$1.5M186%N/AN/A
#8
$60.1M338-14%$286.6MN/A
#9
$2.1M21N/AN/AN/A
#10
$17.2M1231%$56.8MN/A
Add Company

What Is Lantern Pharma?

Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR platform helps to provide rapid, meaningful insight to both of these central problems in oncology. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.

keywords:N/A

N/A

Total Funding

31

Number of Employees

$1.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.1M31-9%N/A
#2
$3.6M31N/AN/A
#3
$7.2M310%N/A
#4
$3.6M31-6%N/A
#5
$6.1M310%N/A